Press "Enter" to skip to content

New patent for Ucb Inc drug VIMPAT

0
Copyright © DrugPatentWatch. Originally published at New patent for Ucb Inc drug VIMPAT

Annual Drug Patent Expirations for VIMPAT
Annual Drug Patent Expirations for VIMPAT

Vimpat is a drug marketed by Ucb Inc and is included in three NDAs. It is available from three suppliers. There is one patent protecting this drug and three Paragraph IV challenges.

VIMPAT drug price trends.

Drug patent litigation for VIMPAT.

This drug has nineteen patent family members in eleven countries.

The generic ingredient in VIMPAT is lacosamide. Three suppliers are listed for this compound. Additional details are available on the lacosamide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Ucb Inc drug VIMPAT
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions